SHILPA MEDICARE LTD. - 530549 - Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 20, 2023 for Deepak Kumar Innani SHILPA MEDICARE LTD. - 530549 - Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 20, 2023 for Ramakant Innani, on behalf of Promoters SHILPA MEDICARE LTD. - 530549 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 20, 2023 for Dharmavati Bhutada, Keshav Bhutada & Madhav Bhutada SHILPA MEDICARE LTD. - 530549 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 20, 2023 for Deepak Kumar Innani SHILPA MEDICARE LTD. - 530549 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 20, 2023 for Ramakant Innani, on behalf of Promoters
Shilpa Medicare rallies 5% on TGA Australia approval to Bengaluru unit
The approval is for the manufacturing, labeling, packaging and testing of medicinal oral mouth dissolving films. SHILPA MEDICARE LTD. - 530549 - Intimation U/R 30 Of The SEBI(LODR) Regulations
APPROVAL BY TGA, AUSTRALIA FOR SHILPA MEDICARE LIMITED UNIT VI, BENGALURU. SHILPA MEDICARE LTD. - 530549 - Intimation U/R Of The SEBI (LODR) Regulations - Reg. 30 & 30(A)
Shilpa Medicare Limited has entered Share subscription and Shareholders Agreement with Ash Ingredients Inc to sell 4% of its Stake held in Sravathi Advance Process Technologies Private Limited SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q2 conference call SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Q2 FY24 Conference Call held on Saturday, 11 November 2023 at 11.00 AM IST